BRS3 Antibody

What is BRS3 and why are antibodies against it important for research?

BRS3 (Bombesin receptor subtype-3) is an orphan G protein-coupled receptor from the bombesin receptor family. In humans, the canonical protein has 399 amino acid residues with a mass of approximately 44.4 kDa and is primarily localized in the cell membrane . Despite structural similarity to other bombesin receptors, BRS3 has very low affinity for bombesin itself .

BRS3 antibodies are crucial research tools because they enable detection and characterization of this receptor in various experimental contexts. They are particularly valuable for studying BRS3's involvement in:

• GPCR signaling pathways

• Carbohydrate metabolism and homeostasis

• Energy expenditure regulation

• Body temperature control

• Heart rate and blood pressure regulation

Western blot, ELISA, immunofluorescence, and immunohistochemistry are common applications for these antibodies .

Where is BRS3 primarily expressed in mammalian tissues?

BRS3 expression has been reported in multiple tissues:

• Lung (both normal and cancerous)

• Nasal mucosa

• Placenta

• Uterus

• Brain (particularly in hypothalamic nuclei)

• Kidney (cancer libraries)

More specifically, within the brain, BRS3 is highly expressed in:

• Preoptic area (POA)

• Paraventricular nucleus of the hypothalamus (PVH)

• Dorsomedial hypothalamus (DMH)

• Bed nucleus of the stria terminalis (BNST)

• Medial posterodorsal amygdala (MePD)

• Lateral parabrachial nucleus (LPB)

This expression pattern makes BRS3 a valuable marker for investigating neural circuits involved in metabolic regulation.

What are the recommended applications and protocols for BRS3 antibody use in research?

Based on available data, the following applications are recommended for BRS3 antibodies:

When establishing protocols, researchers should:

• Begin with the manufacturer's recommended dilution

• Include appropriate positive controls (lung tissue is often effective)

• Validate specificity with blocking peptides when available

• Consider fixation method impacts on epitope accessibility

How can researchers validate the specificity of BRS3 antibodies in their experimental systems?

Validating antibody specificity is crucial for reliable results. Recommended approaches include:

• Genetic controls: Use tissues from BRS3 knockout models as negative controls

• Peptide competition assays: Pre-incubate antibody with the immunizing peptide to confirm specificity

• Multiple antibody concordance: Use antibodies targeting different epitopes of BRS3 to confirm staining patterns

• Correlation with mRNA expression: Compare protein detection with mRNA expression patterns using in situ hybridization

• Recombinant expression systems: Test antibody in cell lines with controlled BRS3 expression levels

As demonstrated in the Brs3-Cre mouse model validation, in situ hybridization can confirm that neurons expressing BRS3 mRNA also express the expected reporter protein and vice versa .

How can BRS3 antibodies be used to investigate neuronal circuits regulating body temperature and metabolism?

BRS3 antibodies are valuable tools for dissecting the neural circuitry controlling temperature regulation and metabolism. Methodological approaches include:

• Circuit mapping: Use BRS3 antibodies in combination with other neural markers to identify connectivity between BRS3-expressing neurons and other regions

• Functional validation: Combine immunohistochemistry with Fos labeling to identify activated BRS3 neurons during physiological challenges (e.g., cold exposure)

• Optogenetic and chemogenetic manipulations: Use BRS3 antibodies to confirm expression of viral constructs in the correct neuronal populations

Research has shown that BRS3 neurons in distinct brain regions serve different functions:

• Preoptic area (POA) BRS3 neurons increase body temperature and heart rate when activated

• Dorsomedial hypothalamus (DMH) BRS3 neurons regulate body temperature, energy expenditure, heart rate, and blood pressure

• Paraventricular nucleus (PVH) BRS3 neurons suppress food intake but don't affect body temperature

What approaches can be used to study BRS3 signaling mechanisms using antibodies?

Studying BRS3 signaling pathways requires sophisticated approaches:

• Phospho-specific antibodies: Use antibodies against phosphorylated downstream signaling molecules (e.g., ERK, CREB) to track activation

• Co-immunoprecipitation (Co-IP): Use BRS3 antibodies to pull down receptor complexes and identify interacting proteins

• Proximity ligation assays: Detect protein-protein interactions involving BRS3 in intact cells

• Single-cell analysis: Combine BRS3 immunostaining with other markers to characterize receptor expression at the single-cell level

For example, research has shown that leptin activates some BRS3 neurons, as evidenced by increased STAT3 phosphorylation in specific hypothalamic regions (MPA, MnPO, dDMH/DHA, and vDMH) but not in others (PVH, PBN) .

How can researchers address challenges with BRS3 antibody specificity and sensitivity?

Common challenges with BRS3 antibodies include:

• Cross-reactivity: BRS3 belongs to a family of related receptors, raising concerns about antibody specificity

  • Solution: Use peptide competition assays and knockout controls when available

• Low expression levels: BRS3 may be expressed at low levels in some tissues

  • Solution: Consider signal amplification methods such as tyramide signal amplification (TSA)

• Epitope masking: Post-translational modifications (like glycosylation) may affect epitope recognition

  • Solution: Use multiple antibodies targeting different epitopes; consider deglycosylation treatments

• Fixation artifacts: Some epitopes may be sensitive to fixation methods

  • Solution: Compare multiple fixation protocols to optimize antigen preservation

Research notes that BRS3 undergoes glycosylation as a post-translational modification, which can affect antibody binding .

What are the key considerations when designing experiments to investigate BRS3 function in disease models?

When studying BRS3 in disease contexts, researchers should consider:

• Model selection: Choose appropriate disease models based on BRS3 involvement

  • Obesity models are particularly relevant as BRS3 knockout mice develop metabolic defects and obesity

• Temporal dynamics: Monitor BRS3 expression changes over disease progression

  • Use time-course experiments with consistent antibody detection methods

• Regional specificity: Examine BRS3 expression in disease-relevant tissues

  • For metabolic disorders, focus on hypothalamic nuclei, particularly DMH and PVH

• Functional correlation: Correlate BRS3 expression with physiological parameters

  • Measure body temperature, energy expenditure, food intake, and cardiovascular parameters

Research has demonstrated that BRS3 neurons in different brain regions regulate distinct physiological processes, highlighting the importance of region-specific analysis .

How might BRS3 antibodies contribute to the development of therapeutics for metabolic disorders?

BRS3 antibodies can facilitate therapeutic development through several approaches:

• Target validation: Confirm BRS3 presence and accessibility in target tissues

• Pharmacodynamic markers: Use antibodies to monitor receptor levels/internalization following drug treatment

• Mechanism of action studies: Investigate the signaling events triggered by BRS3 agonists

Research shows that BRS3 agonists (like MK-5046) increase body temperature, energy expenditure, heart rate, and blood pressure while decreasing food intake . These findings suggest BRS3 may be a viable therapeutic target for obesity, with antibodies serving as critical tools for target validation and drug development.

What emerging techniques could enhance the utility of BRS3 antibodies in neuroscience research?

Several cutting-edge approaches could expand BRS3 antibody applications:

• Tissue clearing and 3D imaging: Map complete BRS3 neuronal networks throughout the brain

• Multiplexed immunofluorescence: Simultaneously visualize BRS3 with multiple other markers to better characterize expressing cells

• Mass cytometry/imaging mass cytometry: Analyze dozens of parameters simultaneously in BRS3-expressing cells

• Super-resolution microscopy: Examine subcellular localization of BRS3 and its interaction partners at nanoscale resolution

• Spatial transcriptomics with protein validation: Correlate BRS3 protein expression with transcriptional profiles in the same tissue section

These approaches would help address current questions about the heterogeneity of BRS3-expressing neurons, particularly given the evidence that long-term inactivation of POA BRS3 neurons causes increased body temperature variability, with RNA expression profiles suggesting multiple types of POA BRS3 neurons .